Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2855807/0/en/Evaxion-and-Undisclosed-Collaborator-Announce-Encouraging-Results-for-EVX-B1-Vaccine-Antigens-Against-Staphylococcus-Aureus-Infection.html
https://www.globenewswire.com/news-release/2024/03/27/2853051/0/en/Evaxion-Announces-Business-Update-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2024/03/19/2848452/0/en/Evaxion-Hosts-R-D-Day-and-Unveils-the-Broad-Potential-of-Its-AI-Immunology-Platform.html
https://www.globenewswire.com//news-release/2024/02/29/2837859/0/en/Evaxion-to-Host-R-D-Day-on-March-19-2024-Highlighting-its-Latest-Technology-Innovations.html
https://www.globenewswire.com//news-release/2024/02/20/2831708/0/en/Evaxion-Announces-Successful-Completion-of-the-Initial-Phases-of-Ongoing-Vaccine-Collaboration-with-MSD.html
https://www.globenewswire.com//news-release/2024/02/07/2825208/0/en/Evaxion-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html
https://www.globenewswire.com//news-release/2024/02/06/2824339/0/en/Evaxion-Announces-Closing-of-15-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/02/01/2822093/0/en/Evaxion-Biotech-Announces-Pricing-of-15-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/01/24/2815320/0/en/Evaxion-to-Develop-Tailored-Novel-Cancer-Vaccines-Based-upon-a-New-Untapped-Source-of-AI-Discovered-Targets.html
https://www.globenewswire.com//news-release/2024/01/22/2813493/0/en/Evaxion-Announces-Completion-of-ADS-Ratio-Change.html